Bristol-Myers Squibb agreed to acquire biopharmaceutical company Celgene in a $74 billion cash and stock transaction. Morgan Stanley Senior Funding and MUFG Bank will provide the debt financing to support the transaction.
Oaktree Provides $150MM Term Loan to Sorrento Therapeutics
November 8, 2018
Sorrento Therapeutics, a clinical-stage immunotherapy biotech company, closed a debt financing for up to $150 million. The financing was provided by funds and accounts managed by Oaktree Capital Management.
Athyrium Provides $110MM Facility to Kala Pharmaceuticals
October 3, 2018
Kala Pharmaceuticals closed a $110 million credit facility with funds managed by Athyrium Capital Management. Morgan Stanley acted as sole structuring agent on the transaction.
Rabobank, Santander, Others Support Sainsbury Acquisition of Asda
July 5, 2018
Reuters reported UK supermarket Sainsbury’s closed £3.5 billion ($4.5 billion) in syndicated loans in order to facilitate an acquisition of Walmart’s Asda, which is valued at £7.3 billion ($9.7 billion).
JPMorgan Agents Zebra Technologies Debt Restructuring
June 1, 2018
Zebra Technologies restructured its debt to reduce interest costs while maximizing financial flexibility.
Goldman Sachs Supports Fusion Birch Buy
May 8, 2018
Fusion, a provider of cloud services, closed its acquisition of the business services unit of Birch Communications. Goldman Sachs served as administrative agent for $680 million in financing to support the buy.
Credit Agricole Replaces Morgan Stanley in Michelin Buy
April 9, 2018
Michelin terminated its previously announced credit facility with Morgan Stanley to support the acquisition of Fenner and entered into a new commitment with Credit Agricole.
